The Virus

COVID-19

SARS-CoV2 / COVID-19
Informations and research papers from outstanding scientists, specialists, professionals and expert organizations explaining SARS-CoV2 and  COVID-19.  All the facts are from original documents, research studies and papers or statements from scientists, experts and official sources. 

SARS-CoV2
SARS-CoV2 is an RNA virus which causes the disease COVID-19. Although SARS-CoV2 is a new virus it actually belongs to the group of common cold Human coronaviruses (CoVs). “Coronavirus” is a generic term that includes a large family of viruses.

Actually there are multiple types of coronaviruses, some of which commonly cause mild upper-respiratory tract illnesses. Common cold coronaviruses are ubiquitous; wherever investigators have looked, they have been detected. Their seasonality depends, in part, on the climate.
Since there are many coronavirus types every newly detected virus receives a specific name. In COVID-19, ‘CO’ stands for ‘corona,’ ‘VI’ for ‘virus,’ ‘D’ for disease and 19 indicates the year it was discovered.
SARS-CoV2 stands for Severe Acute Respiratory Syndrome CoronaVirus 2 and is actually the virus that causes COVID-19 (the disease). Although SARS-CoV2 has genetic similarities to SARS-CoV, the virus that caused an outbreak of severe acute respiratory syndrome (SARS) in 2002-2003 it is not the same virus.

Like many other DNA and RNA viruses coronaviruses appear to be an ancient viral lineage and there seems to be an ancient coevolutionary relationship between coronaviruses and their natural hosts.
Until today there have been seven coronavirus types which have been associated with diseases in humans. The first one was already discovered in the 1960s.
Studies linked them to as much as one-third of upper respiratory tract infections during winter outbreaks. SARS has been discovered in 2002.

SARS-CoV-2, is an RNA virus, which are more prone to changes and mutations compared with DNA viruses like smallpox. So, as it has been passing from person to person over the past months, it has been, and continues to be, mutating. Mutation rate drives viral evolution and genome variability, thereby enabling viruses to escape host immunity and to develop drug resistance.
RNA viruses are characterized by a high mutation rate, up to a million times higher than that of their hosts. The virus is evolving and European, North American and Asian strains might coexist, each of them characterized by a different mutation pattern.

Over many years there have been six coronavirus serotypes associated with disease in humans: HCoV-229E, HCoV-NL63, HCoV-OC43, HCoV-HKU1, SARS-CoV, SARS-CoV-2, and MERS-CoV. Since our bodies had to deal with different coronaviruses in the past, it appears that most people already have a congenital or general immunity to e.g. influenza and other viruses.

A study in the journal Cell shows that most people neutralize the coronavirus by mucosal and cellular immunity (T-cells), while experiencing few or no symptoms. A study detected SARS-CoV-2-reactive CD4+ T cells in ∼40%–60% of unexposed individuals, suggesting cross-reactive T cell recognition between circulating “common cold” coronaviruses and SARS-CoV-2.

Most people therefore already have a congenital or cross-immunity because they were already in contact with variants of the same virus.
That is probably one of the causes why most people who test positive (PCR) have no complaints. Their immune system is strong enough. So strengthening natural immunity is a very logical and healthy approach.

SARS-CoV-2 Vermehrungszyklus (German)

February 12, 2021
Public is Being “Led to Their Downfall” With False Coronavirus Narrative — Sucharit Bhakdi MD

Genomic epidemiology of novel coronavirus – Global subsampling
https://nextstrain.org/ncov/global

December 13, 2020
SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome
https://www.biorxiv.org/content/10.1101/2020.12.12.422516v1

June 25, 2020
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
“We
detected SARS-CoV-2-reactive CD4+ T cells in 40%–60% of unexposed individuals, suggesting crossreactive T cell recognition between circulating ‘‘common cold’’ coronaviruses and SARS-CoV-2.”
https://www.cell.com/cell/fulltext/S0092-8674(20)30610-3

June 11, 2020
40 FOI requests around the world have confirmed that Covid 19 has never been isolated

April 22, 2020
Emerging SARS-CoV-2 mutation hot spots 

https://pubmed.ncbi.nlm.nih.gov/32321524/

April 14, 2020
Thoughts and Concerns Regarding the New Corona Virus
by John Hardie BDS, MSc, PhD, FRCDC
https://theinfectiousmyth.com/coronavirus/COVIDThoughtsConcerns_JohnHardie.pdf

March 19, 2020
Status of COVID-19
As of 19 March 2020, COVID-19 is no longer considered to be a high consequence infectious disease (HCID) in the UK.
https://www.gov.uk/guidance/high-consequence-infectious-diseases-hcid#status-of-covid-19

February 15, 2020
Human Coronavirus Types
https://www.cdc.gov/coronavirus/types.html

January 24, 2020
A novel coronavirus outbreak of global health concern
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30185-9/fulltext

April 17, 2013
A case for the ancient origin of coronaviruses
https://pubmed.ncbi.nlm.nih.gov/23596293/

2005
New human coronavirus
“The human coronaviruses (HCoV) are envelopedviruses, which carry a plus-sense RNA genome appro-ximately 30 kb in length. The prototype HCoV, 229E,and OC43, were identified in the 1960s [Hamre andProcknow, 1966] but until the discovery of the SARS-CoV, received relatively little attention as humanpathogens beyond their causal role in the common cold.”
https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.20288

2002
Rhinovirus and Coronavirus Infection
https://academic.oup.com/jid/article/185/9/1338/938156

January 23, 2021
Return to Wuhan: What Life Is Like One Year Later / NBC Nightly News
Dr. Wu Zunyou / Chinese Center For Disease Control
“They didn’t isolate the virus. That’s the issue.”

March 8, 2021
Canadian Doctors Speak Out

January 25, 2021
Prof. Sucharit Bhakdi – Complete Covid TRUTH!

Life cycle of SARS-CoV

Status of COVID-19
As of 19 March 2020, COVID-19 is no longer considered to be a high consequence infectious disease (HCID) in the UK.
https://www.gov.uk/guidance/high-consequence-infectious-diseases-hcid#status-of-covid-19

Genomic epidemiology of novel coronavirus – Global subsampling
https://nextstrain.org/ncov/global

 

June 25, 2020
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
“We
detected SARS-CoV-2-reactive CD4+ T cells in 40%–60% of unexposed individuals, suggesting crossreactive T cell recognition between circulating ‘‘common cold’’ coronaviruses and SARS-CoV-2.”
https://www.cell.com/cell/fulltext/S0092-8674(20)30610-3

 

All information is deemed accurate but not guaranteed and should be independently verified.